1. Home
  2. ZLAB vs WTM Comparison

ZLAB vs WTM Comparison

Compare ZLAB & WTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • WTM
  • Stock Information
  • Founded
  • ZLAB 2013
  • WTM 1980
  • Country
  • ZLAB China
  • WTM Bermuda
  • Employees
  • ZLAB N/A
  • WTM N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • WTM Property-Casualty Insurers
  • Sector
  • ZLAB Health Care
  • WTM Finance
  • Exchange
  • ZLAB Nasdaq
  • WTM Nasdaq
  • Market Cap
  • ZLAB 4.0B
  • WTM 4.7B
  • IPO Year
  • ZLAB 2017
  • WTM N/A
  • Fundamental
  • Price
  • ZLAB $33.34
  • WTM $1,835.59
  • Analyst Decision
  • ZLAB Buy
  • WTM
  • Analyst Count
  • ZLAB 6
  • WTM 0
  • Target Price
  • ZLAB $57.22
  • WTM N/A
  • AVG Volume (30 Days)
  • ZLAB 537.8K
  • WTM 28.4K
  • Earning Date
  • ZLAB 08-07-2025
  • WTM 08-07-2025
  • Dividend Yield
  • ZLAB N/A
  • WTM 0.05%
  • EPS Growth
  • ZLAB N/A
  • WTM N/A
  • EPS
  • ZLAB N/A
  • WTM 79.93
  • Revenue
  • ZLAB $427,799,000.00
  • WTM $2,578,600,000.00
  • Revenue This Year
  • ZLAB $42.62
  • WTM N/A
  • Revenue Next Year
  • ZLAB $55.12
  • WTM N/A
  • P/E Ratio
  • ZLAB N/A
  • WTM $22.90
  • Revenue Growth
  • ZLAB 32.56
  • WTM 12.16
  • 52 Week Low
  • ZLAB $18.91
  • WTM $1,678.87
  • 52 Week High
  • ZLAB $44.34
  • WTM $2,023.00
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 43.89
  • WTM 54.32
  • Support Level
  • ZLAB $31.79
  • WTM $1,822.00
  • Resistance Level
  • ZLAB $35.45
  • WTM $1,850.82
  • Average True Range (ATR)
  • ZLAB 1.00
  • WTM 32.66
  • MACD
  • ZLAB -0.22
  • WTM 1.22
  • Stochastic Oscillator
  • ZLAB 31.12
  • WTM 63.33

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About WTM White Mountains Insurance Group Ltd.

White Mountains Insurance Group Ltd is engaged in the business of making opportunistic and value-oriented acquisitions of businesses and assets in the insurance, financial services, and related sectors, operating these businesses and assets through its subsidiaries and, if and when attractive exit valuations become available, disposing of these businesses and assets. The company conducts its business in five areas: property and casualty insurance and reinsurance, municipal bond reinsurance, capital solutions for asset and wealth management firms, property and casualty insurance distribution, and other operations.

Share on Social Networks: